{"id":{"repo_id":"whiterose","oai_identifier":"oai:etheses.whiterose.ac.uk:18878"},"canonical_url":"https://search.ndltd.org/etd/whiterose/oai:etheses.whiterose.ac.uk:18878","repository":{"repo_id":"whiterose","name":"White Rose University Consortium","base_url":"https://etheses.whiterose.ac.uk/cgi/oai2"},"display":{"title":"Characterisation of the immuno-inflammatory response following operative adolescent idiopathic scoliosis and biological properties of osteoprogenitor cells harvested from vertebral bodies compared to iliac crest.","abstract":"In patients undergoing adolescent idiopathic scoliosis (AIS) surgery the yield and differentiation capacities of mesenchymal stem cells (MSCs) from vertebral body (VB) and iliac crest (IC) bone marrow (BM) were investigated comparing the effectiveness of two MSC-harvesting procedures [density gradient centrifugation (Lymphoprep, LMP) and red cell lysis (Ammonium Chloride, AC)]. The burden of surgery of 3 surgical approaches (posterior, posterior-costoplasty, antero-posterior), for AIS correction was also quantified. In 18 patients 10ml of BM were aspirated intraoperatively from IC and VB and MSCs were isolated using AC and LMP harvesting procedures. MSCs were enumerated and phenotypically characterised using colony-forming-unit-fibroblast (CFU-F), flow cytometry and trilineage differentiation assays. For the immuno-inflammatory study 23 patients were recruited. ELISA-assays were performed on serum from 4ml of peripheral blood, at 6 peri-operative time-points (T), measuring 4 cytokines [(Interleukin) IL-6, IL-10, IL-18 and Procalcitonin (PCT)]. Surgical parameters and gender variability were also analysed. Both IC and VB exhibited similar concentrations of MSCs, however AC yielded significantly more MSC/ml by 1.8-fold (IC, p=0.012) and 1.5-fold (VB, p=0.043), compared to LMP. Calcium and glycosaminoglycan (GAG) concentrations were both significantly higher from VB MSCs, compared to IC [Calcium: AC 8.7-fold (p=0.001), LMP 1.2-fold, GAG: AC 3.8-fold (p=0.0005), LMP 1.9-fold (p=0.003)]. Adipogenesis did not show significant differences. VB AC-harvested MSCs presented a significantly smaller colony area by 1.9-fold (p=0.039), compared to IC AC. The post-operative concentrations of IL-6 and IL-10 were always significatintly elevated at T2 and T3 points, in all 3 approaches (p<0.01) with antero-posterior approach presenting the highest levels followed by posterior-costoplasty and posterior approaches. Although prolonged procedures and gender type affected cytokine concentrations, their levels were not statistically significant. In summary, AC isolated more effectively MSCs, without affecting their function. VBBM MSCs demonstrated higher osteo- and chondro-genic differentiation capacities, representing a valid source of MSCs in spinal surgery. The surgical stress reaction quantified with immune-inflammatory markers, was higher in more aggressive and extensile procedures, suggesting greater vigilance in identifying and preventing complications.","abstract_html":"In patients undergoing adolescent idiopathic scoliosis (AIS) surgery the yield and differentiation capacities of mesenchymal stem cells (MSCs) from vertebral body (VB) and iliac crest (IC) bone marrow (BM) were investigated comparing the effectiveness of two MSC-harvesting procedures [density gradient centrifugation (Lymphoprep, LMP) and red cell lysis (Ammonium Chloride, AC)]. The burden of surgery of 3 surgical approaches (posterior, posterior-costoplasty, antero-posterior), for AIS correction was also quantified. In 18 patients 10ml of BM were aspirated intraoperatively from IC and VB and MSCs were isolated using AC and LMP harvesting procedures. MSCs were enumerated and phenotypically characterised using colony-forming-unit-fibroblast (CFU-F), flow cytometry and trilineage differentiation assays. For the immuno-inflammatory study 23 patients were recruited. ELISA-assays were performed on serum from 4ml of peripheral blood, at 6 peri-operative time-points (T), measuring 4 cytokines [(Interleukin) IL-6, IL-10, IL-18 and Procalcitonin (PCT)]. Surgical parameters and gender variability were also analysed. Both IC and VB exhibited similar concentrations of MSCs, however AC yielded significantly more MSC/ml by 1.8-fold (IC, p=0.012) and 1.5-fold (VB, p=0.043), compared to LMP. Calcium and glycosaminoglycan (GAG) concentrations were both significantly higher from VB MSCs, compared to IC [Calcium: AC 8.7-fold (p=0.001), LMP 1.2-fold, GAG: AC 3.8-fold (p=0.0005), LMP 1.9-fold (p=0.003)]. Adipogenesis did not show significant differences. VB AC-harvested MSCs presented a significantly smaller colony area by 1.9-fold (p=0.039), compared to IC AC. The post-operative concentrations of IL-6 and IL-10 were always significatintly elevated at T2 and T3 points, in all 3 approaches (p&lt;0.01) with antero-posterior approach presenting the highest levels followed by posterior-costoplasty and posterior approaches. Although prolonged procedures and gender type affected cytokine concentrations, their levels were not statistically significant. In summary, AC isolated more effectively MSCs, without affecting their function. VBBM MSCs demonstrated higher osteo- and chondro-genic differentiation capacities, representing a valid source of MSCs in spinal surgery. The surgical stress reaction quantified with immune-inflammatory markers, was higher in more aggressive and extensile procedures, suggesting greater vigilance in identifying and preventing complications.","abstract_has_math":false,"creators":["Fragkakis, Evangelos Minas"],"institution":"University of Leeds","degree_name":"M.D","degree_level":"doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Giannoudis, Gianoudis, Peter V (40% supervision)","Jones, Jones Elena (40% supervision)","Pountos, Pountos Ippokratis (20% supervision)"],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-11","date_published":"2016-11","updated_at":"2026-11-18T22:24:19Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["uk.bl.ethos.729432"],"render_values":[{"text":"uk.bl.ethos.729432","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://etheses.whiterose.ac.uk/id/eprint/18878/1/THESIS%20E%20M%20Fragkakis%2C%209-11-17.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.whiterose.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.whiterose.ac.uk%3A18878","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Giannoudis, Gianoudis, Peter V (40% supervision)","Jones, Jones Elena (40% supervision)","Pountos, Pountos Ippokratis (20% supervision)"]},{"key":"dc:contributor.sponsor","label":"Sponsor","values":["Italian Society Of Trauma and Orthopaedics (SIOT)","Yorkshire Children's Spine Foundation"]},{"key":"dc:creator","label":"Author","values":["Fragkakis, Evangelos Minas"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016-11"]},{"key":"dc:date.issued","label":"Date","values":["2016-11"]},{"key":"dc:publisher.commercial","label":"Dc Publisher Commercial","values":["University of Leeds"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Section of Musculoskeletal Disease (Leeds)","Faculty of Medicine and Health (Leeds)"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Leeds"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://etheses.whiterose.ac.uk/id/eprint/18878/"]},{"key":"dc:relation.references","label":"Dc Relation References","values":["1. Rothman-Simeone. The Spine, Saunders 5th edition 2006, 1st volume, Idiopathic scoliosis, chap:33, 515-534. 2. Divecha HM, Siddique I, Breakwell LM, Millner PA. British Scoliosis Society Members. Complications in spinal deformity surgery in the United Kingdom: 5-year results of the annual British Scoliosis Society National Audit of Morbidity and Mortality. 2014 Apr; 23 Suppl 1:S55-60. 3. Lenke LG, Betz RR, Harms f, Bridwell KH, Clements DH, Lowe TG, Blanke K. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthrodesis. The journal of bone and joint surgery American volume, 2001 Aug;83 -A,B: 1, 169-81. 4. Kal Kaur. Stainless Steel and Titanium in Surgical Implants. AZojomo, Sep 26, 2012. 5. Gail K Smith. Orthopaedic biomaterials, chapter 13, \"Textbook of Small Animal Orthopaedics\" Charles D. Newton, D.V.M., M.S., David M. Nunamaker, V.M.D. Publ: J.B. Lippincott Company, 1985. 6. Reames DL, Smith JS, Fu KM, Polly DW Jr, Ames CP, Berven SH, Perra JH, Glassman SD, McCarthy RE, Knapp RD Jr, Heary R, Shaffrey Cl. Scoliosis Research Society Morbidity and Mortality Committee. Complications in the surgical treatment of 19,360 cases of paediatric scoliosis: a review of the Scoliosis Research Society Morbidity and Mortality database. Spine (Phila Pa 1976), 2011, Aug 15;36(18):1484-91. 7. Robert F Mclain, James E Fleming, Cynthia A Boehm, George F Muschler. Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005 December; 87(12): 2655–2661. 8. Kim DH, Rhim R, Li L, Martha J, Swaim BH, Banco RJ, Jenis LG, Tromanhauser SG. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009 Nov;9(11):886-92. 9. Cahill KS, McCormick PC, Levi AD. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis. J Neurosurg Spine. 2015 Jul;23(1):86-93. 10. Hustedt JW, Blizzard DJ. The controversy surrounding bone morphogenetic proteins in the spine: a review of current research. Yale J Biol Med. 2014 Dec 12;87(4):549-61. 11. Vaccaro AR, Stubbs HA, Block JE. Demineralized bone matrix composite grafting for posterolateral spinal fusion. Orthopedics. 2007 Jul;30(7):567-70. 12. Kang J, An H, Hilibrand A, Yoon ST, Kavanagh E, Boden S. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions. Spine (Phila Pa 1976). 2012 May 20;37(12):1083-91. 214 13. Jäger M, Hernigou P, Zilkens C, Herten M, Li X, Fischer J, Krauspe R. Cell therapy in bone healing disorders. Orthop Rev (Pavia). 2010 Sep 23;2(2):e20. 14. Ugo Del Torto. Lezioni di clinica ortopedica. Italian Ed;8, Piccin, 1990. 15. Schünke, Schulte, Schumacher, Voll, Wesker. Prometheus, Texto y atlas de anatomìa, Tomo 1. Spanish Ed;2, Panamericana, 2011. 16. Attilio Mancini, Carlo Morlacchi. Clinica ortopedica, Manuale-atlante. Italian Ed;4, Piccin, 2003. 17. Thomas P R edi, Richard E Buckley, Christopher G Morgan. AO principles of fracture management, Vol. 1. Ed. 2, Davos : AO Publishing, 2007. 18. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005 Dec;36(12):1392-404. 19. Marsell R, Einhorn TA. The biology of fracture healing. Injury, 2011 Jun;42(6):551-5. 20. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003 Apr 1;88(5):873-84. 21. Marsell R, Einhorn TA The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 2009 Dec;40 Suppl 3:S4-7. 22. Fayaz HC, Giannoudis PV, Vrahas MS, Smith RM, Moran C, Pape HC, Krettek C, Jupiter JB. The role of stem cells in fracture healing and nonunion. Int Orthop. 2011 Nov;35(11):1587-97. 23. Ravindra VM, Godzik J, Dailey AT, Schmidt MH, Bisson EF, Hood RS, Cutler A, Ray WZ. Vitamin D Levels and 1-Year Fusion Outcomes in Elective Spine Surgery: A Prospective Observational Study. Spine (Phila Pa 1976). 2015 Oct 1;40(19):1536-41. 24. Adams CI, Keating JF, Court-Brown CM. Cigarette smoking and open tibial fractures. Injury. 2001 Jan;32(1):61-5. 25. Hoogduijn MJ, Cheng A, Genever PG. Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev. 2009 Jan-Feb;18(1):103-12. 26. Brown CW, Orme TJ, Richardson HD. The rate of pseudoarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: a comparison study. Spine (Phila Pa 1976). 1986 Nov;11(9):942-3. 27. Hermann PC, Webler M, Bornemann R, Jansen TR, Rommelspacher Y, Sander K, Roessler PP, Frey SP, Pflugmacher R. Influence of smoking on spinal fusion after spondylodesis surgery: A comparative clinical study. Technol Health Care. 2016 Apr 21. 28. Laytragoon-Lewin N, Bahram F, Rutqvist LE, Turesson I, Lewin F. Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. Anticancer Res. 2011 May;31(5):1527-34. 215 29. Einhorn TA, Bonnarens F, Burstein AH. The contributions of dietary protein and mineral to the healing of experimental fractures. A biomechanical study. J Bone Joint Surg Am. 1986 Dec;68(9):1389-95. 30. Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012 Mar;73(3):348-62. 31. Tétrault M, Courtois F. Use of psychoactive substances in persons with spinal cord injury: a literature review. Ann Phys Rehabil Med. 2014 Dec;57(9-10):684-95. 32. Ronis MJ, Mercer K, Chen JR. Effects of nutrition and alcohol consumption on bone loss. Curr Osteoporos Rep. 2011 Jun;9(2):53-9. 33. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br. 2000 Jul;82(5):655-8. 34. Kameda H, Amano K, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Suzuki K, Takeuchi T. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. Intern Med. 2009;48(22):1931-8. Epub 2009 Nov 16. 35. Boursinos LA, Karachalios T, Poultsides L, Malizos KN. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing? J Musculoskelet Neuronal Interact.2009 Jan-Mar;9(1):44-52. 36. Martín-Esteve I, Aparicio-Espinar M, Hernández-Gañan J, Narváez J. Vertebral osteonecrosis as a complication of corticosteroid therapy: the intravertebral vacuum cleft sign. Reumatol Clin. 2012 Nov-Dec;8(6):375-7. 37. LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM, Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM, Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Rauch F, Siminoski K, Ward LM; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Paediatric Patients With Rheumatic Disorders. J Bone Miner Res. 2015 Sep;30(9):1667-75. 38. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007 Sep;38 Suppl 4:S3-6. 39. Tannoury CA, An HS. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J. 2014 Mar 1;14(3):552-9. 40. Dimitriou R, Carr IM, West RM, Markham AF, Giannoudis PV. Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway. BMC Musculoskelet Disord. 2011 Feb 10;12:44. 41. Hangama C. Fayaz, Peter V. Giannoudis, Mark S. Vrahas, Raymond Malcolm Smith, Christopher Moran, Hans Christoph Pape, Christian Krettek, Jesse B. Jupiter. The role of stem cells in fracture healing and nonunion. 8 Int Orthop. 2011 Nov; 35(11): 1587–1597. 216 42. Stewart Sell, Stem cells handbook. Ch: 10., Humana Press Inc. Totowa, New Jersey, 2004. 43. Elena Jones, Xuebin Yang, Peter Giannoudis, Dennis McGonagle. Mesenchymal Stem Cells and Skeletal Regeneration. Academic Press; ed. 1, 20 Feb 2013. 44. Becker AJ, McCulloch EA, Till JE. Pillars article: Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963. 197:452-454. J Immunol. 2014 Jun 1;192(11):4945-7. 45. Huang S, Leung V, Peng S, Li L, Lu FJ, Wang T, Lu W, Cheung KM, Zhou G. Developmental definition of MSCs: new insights into pending questions. Cell Reprogram. 2011 Dec;13(6):465-72. 46. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006 Apr;54(4):1209-21. 47. De Bari C, Dell'Accio F, Karystinou A, Guillot PV, Fisk NM, Jones EA, McGonagle D, Khan IM, Archer CW, Mitsiadis TA, Donaldson AN, Luyten FP, Pitzalis C. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 2008 Jan;58(1):240-50. 48. Dennis JE, Carbillet JP, Caplan AI, Charbord P.The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs. 2002;170(2-3):73-82. 49. Hernigou P, Homma Y, Flouzat Lachaniette CH, Poignard A, Allain J, Chevallier N, Rouard H. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop. 2013 Nov;37(11):2279-87. 50. Kitchel SH, Wang MY, Lauryssen CL. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 2005 Oct;57(4 Suppl):286-9; discussion 286-9. 51. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 1997 Nov;79(11):1699-709. 52. McLain RF, Boehm CA, Rufo-Smith C, Muschler GF. Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J 2009 Dec;9(12):995-1002. 53. Hustedt JW, Jegede KA, Badrinath R, Bohl DD, Blizzard DJ. Optimal aspiration volume of vertebral bone marrow for use in spinal fusion. Grauer JN.Spine J. 2013 Oct;13(10):1217-22. 54. Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, Wagner W. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy 2008;10(7):676-85. 55. Carrancio S, López-Holgado N, Sánchez-Guijo FM, Villarón E, Barbado V, Tabera S, Díez-Campelo M, Blanco J, San Miguel JF, Del Cañizo MC. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008 Aug;36(8):1014-21. 217 56. Ahmadbeigi N, Soleimani M, Babaeijandaghi F, Mortazavi Y, Gheisari Y, Vasei M, Azadmanesh K, Rostami S, Shafiee A, Nardi NB. The aggregate nature of human mesenchymal stromal cells in native bone marrow. Cytotherapy. 2012 Sep;14 (8):917-24. 57. Horn P, Bork S, Wagner W. Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. Methods Mol Biol 2011;698:23-35. 58. Soukup T, Mokrý J, Karbanová J, Pytlík R, Suchomel P, Kucerová L. Mesenchymal stem cells isolated from the human bone marrow: cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Medica (Hradec Kralove) 2006;49(1):27-33. 59. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 60. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec;46(12):3349-60. 61. Hernigou P, Flouzat Lachaniette CH, Delambre J, Chevallier N, Rouard H. Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence? Int Orthop. 2014 Sep;38(9):1825-35. 62. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, Neumann U, Scheding S. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 2004 Sep 27;78(6):925-9. 63. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol. 2008;52(8):1023-32. 64. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 2008 Feb;58(2):501-10. 65. Bridget M. Deasy, Jordan E. Anderson, Shannon Zelina Regulatory Issues in the Therapeutic Use of Stem Cells, Regenerative Medicine and Tissue Engineering, ch.9, 2013. 66. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996 Aug;(329):300-309. 67. Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech. 2005 Feb;18 Suppl:S77-81. 68. Woo-Kie Min, Jae-Sung Bae, Byung-Chul Park, In-Ho Jeon, Hee Kyung Jin, Min-Jung Son, Eui Kyun Park, Shin-Yoon Kim. Proliferation and osteoblastic differentiation of bone marrow stem cells: comparison of vertebral body and iliac crest. Eur Spine J (2010) 19:1753–1760. 218 69. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. 70. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005 Jul;87(7):896-902. 71. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005 Jul;87(7):1430-7. 72. Ruetze M, Richter W. Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity. Expert Rev Mol Med. 2014 May 9;16:e9. 73. Braem K, Lories RJ. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine. 2012 May;79(3):243-8. 74. Giannoudis PV, Pountos I. Tissue regeneration. The past, the present and the future. Injury. 2005 Nov;36 Suppl 4:S2-5. 75. Kouroupis D, Baboolal TG, Jones E, Giannoudis PV. Native multipotential stromal cell colonization and graft expander potential of a bovine natural bone scaffold. J Orthop Res 2013 Dec;31(12):1950-8. 76. Vieira MH, Oliveira RJ, Eça LP, Pereira IS, Hermeto LC, Matuo R, Fernandes WS, Silva RA, Antoniolli AC. Therapeutic potential of mesenchymal stem cells to treat Achilles tendon injuries. Genet Mol Res. 2014 Dec 12;13(4):10434-49. 77. Levy M, Boulis N, Rao M, Svendsen CN. Regenerative cellular therapies for neurologic diseases. Brain Res. 2016 May 1;1638(Pt A):88-96. 78. Ringe J, Sittinger M. Tissue engineering in the rheumatic diseases. Arthritis Res Ther 2009;11(1):211. 79. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M.Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006 Jan;24(1):74-85. Epub 2005 Aug 11. 80. Raynaud CM, Yacoub MH. Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? Time, Swiss-Ami, Cellwave, Poseidon And C-Cure. Glob Cardiol Sci Pract. 2013 Nov 1;2013(3):207-11. 2013. 81. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000 Feb;127(2):117-26. 82. Giannoudis PV, Smith RM, Bellamy MC, Morrison JF, Dickson RA, Guillou PJ. Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures; an analysis of the second hit. Journal Bone Joint Surgery (Br) 1999;81:356-361. 83. Giannoudis PV, Smith RM, Bellamy MC, Dickson RA, Guillou PJ. Immune reactivity following stabilisation of femoral fractures: A prospective study assessing the release of molecular mediators. Shock 2000;13:138-139. 219 84. Giannoudis PV. Surgical priorities in damage control in polytrauma. J Bone Joint Surg Br 2003;85:478-83. 85. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury 2003;34:397-404. 86. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med 1996;24:162-172. 87. Giannoudis PV, Smith PM, Ramsden CW. Molecular mediators and trauma: effects of accidental trauma on the production of plasma elastase, IL-6, ICAM-1 and E-selectin. Injury 1996;27:376-377. 88. Giannoudis PV Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 2004 ;86:313-323. 89. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990;Apr;170(4):363-378. 90. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 1990;73:308-327. 91. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury 2007 Dec;38(12):1358-64. 92. Blauth M, Knop C, Bastian L, Krettek C, Lange U. Complex injuries of the spine. Orthopade. 1998 Jan;27(1):17-31. 93. Waydhas C, Nast-Kolb D, Kick M, Richter-Turtur M, Trupka A, Machleidt W, Jochum M, Schweiberer L. Operative injury in spinal surgery in the management of polytrauma patients. Unfallchirurg. 1993 Feb;96(2):62-5. 94. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosup- pression? Langenbecks Arch Surg. 2004 Nov;389(6):475-84. 95. DeLong WG Jr, Born CT. Cytokines in patients with polytrauma. Clin Orthop Relat Res. 2004 May;(422):57-65. 96. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006 Nov;141(11):1132-40. 97. Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Büller HR, Hoek FJ, Horikx J, ten Cate JW. Interleukin-6 mediates host defence responses induced by abdominal surgery. Surgery 1993 Sep;114:56&70. 98. Weiss HR, Godall D. Rate of complications in scoliosis surgery-a systematic review of the Pub Med literature. Scoliosis. 2008 Aug 5;3:9. 99. Suzuki N, Kaneko O, Nakayama T, Fukuiya Y, Kuge S, Fujimura Y. Immunological suppression after surgery in scoliosis patients. Eur Spine J. 1997;6(1):39-44. 220 100. Krohn CD, Reikerås O, Aasen AO. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL-10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg. 1999 Feb;165(2):101-9. 101. Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ, Luo ZJ. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013 May 15;6(6):1009-14. 102. Krohn CD, Reikerås O, Aasen AO. Inflammatory cytokines and their receptors in arterial and mixed venous blood before, during and after infusion of drained untreated blood. Transfus Med. 1999 Jun;9(2):125-30. 103. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine (Phila Pa 1976) 2002 Jul 1;27(13):1402-7. 104. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 1996 Feb 1;21(3):271-7. 105. Andrade P, Hoogland G, Garcia MA, Steinbusch HW, Daemen MA, Visser-Vandewalle V. Elevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J. 2013 Apr;22(4):714-20. 106. Ohtori S, Inoue G, Eguchi Y, Orita S, Takaso M, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Sakuma Y, Oikawa Y, Kubota G, Inage K, Sainoh T, Toyone T, Yamauchi K, Kotani T, Akazawa T, Minami S, Takahashi K. Tumor necrosis factor-α immunoreactive cells in nucleus pulposus in adolescent patients with lumbar disc herniation. Spine (Phila Pa 1976). 2013 Mar 15;38(6):459-62. 107. Andrade P, Visser-Vandewalle V, Philippens M, Daemen MA, Steinbusch HW, Buurman WA, Hoogland G. Tumor necrosis factor-α levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between tumor necrosis factor receptor 1 and 2. Pain 2011 Nov;152(11):2645-52. 108. Tak W, Mak and Mary E. Saunders. (2006) The immune response, basic and clinical principles, pp. 481-482. Elsevier Academic Press, China. 109. Giannoudis PV, Smith RM, Perry SL, Windsor AJ, Dickson RA, Bellamy MC. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 2000; Aug;26(8):1076-1081. 110. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World Journal Surgery 1992;5:16-30. 111. Collighan N, Giannoudis PV, Kourgeraki O, Perry SL, Guillou PJ, Bellamy MC. Interleukin 13 and inflammatory markers in human sepsis. Br J Surg 2004 ;91:762-768. 221 112. Hildebrand F, van Griensven M, Giannoudis P, Luerig A, Harwood P, Harms O, Fehr M, Krettek C, Pape HC. Effects of hypothermia and re-warming on the inflammatory response in a murine multiple hit model of trauma. Cytokine 2005 Sep 7;31(5):382-393. 113. Charles A. Dinarello. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011 April 7; 117(14): 3720–3732. 114. H Dinarello CA. Interleukin-1, interleukin-1-receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16(5-6):457-499. 115. Borish LC, HSteinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003 Feb;111(2 Suppl):S460-475. 116. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury 2007 Sep;38 Suppl 4:S23-33. 117. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000 Aug;28(8):875-84. 118. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012;2012:975871. 119. Hildebrand F, Pape HC, Krettek C. The importance of cytokines in the post-traumatic inflammatory reaction. Unfallchirurg. 2005 Oct;108(10):793-4, 796-803. 120. Dinarello CA. Pro-inflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997 Dec;112(6 Suppl.):321S-329S. 121. Ogawa M. Mechanisms of the development of organ failure following surgical insult: the “second attack theory.” Clin Intensive Care 1996;7:34-38. 122. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998;17(1-4):1-52. 123. Tak W, Mak and Mary E. Saunders.(2006) The immune response, basic and clinical principles, pp. 486-487. Elsevier Academic Press, China. 124. Hart PH, Bonder CS, Balogh J, Dickensheets HL, Donnelly RP, Finlay-Jones JJ. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol. 1999 Oct;66(4):575-578. 125. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000 Apr 18;101(15):1767-72. 126. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005 Apr;98(4):1154-62. 127. Alecu M, Geleriu L, Coman G, Gălăţescu L. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis. Rom J Intern Med. 1998 Jul-Dec;36(3-4):251-9. 222 128. Nikolova S, Dikova M, Dikov D, Djerov A, Dzhebir G, Atanasov V, Savov A, Kremensky I. Role of the IL-6 gene in the etiopathogenesis of idiopathic scoliosis. Anal Cell Pathol (Amst). 2015;2015:621893. 129. Mórocz M, Czibula A, Grózer ZB, Szécsényi A, Almos PZ, Raskó I, Illés T. Association study of BMP4, IL-6, Leptin, MMP3, and MTNR1B gene promoter polymorphisms and adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2011 Jan 15;36(2):E123-30. 130. Aulisa L, Papaleo P, Pola E, Angelini F, Aulisa AG, Tamburrelli FC, Pola P, Logroscino CA. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study. Spine (Phila Pa 1976). 2007 Nov 15;32(24):2700-2. 131. Lee JS, Suh KT, Eun IS. Polymorphism in interleukin-6 gene is associated with bone mineral density in patients with adolescent idiopathic scoliosis. J Bone Joint Surg Br. 2010 Aug;92(8):1118-22. 132. Liu Z, Tang NL, Cao XB, Liu WJ, Qiu XS, Cheng JC, Qiu Y. Lack of association between the promoter polymorphisms of MMP-3 and IL-6 genes and adolescent idiopathic scoliosis: a case-control study in a Chinese Han population. Spine (Phila Pa 1976). 2010 Aug 15;35(18):1701-5. 133. Dinarello CA, Novick D, Rubinstein M, Lonnemann G. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure. Blood Purif. 2003;21(3):258-70. 134. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukuda Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T-cells. Nature 1995;378:88-91. 135. Dinarello CA, Fantuzzi G. Interleukin-18 and host defence against infection. J Infect Dis. 2003 Jun 15;187 Suppl 2:S370-84. 136. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol. 2000 Nov;7(6):909-14. 137. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W. Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 2001;16:411-414. 138. Yuan BS, Zhu RM, Braddock M, Zhang XH, Shi W, Zheng MH.Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis. Expert Opin Ther Targets. 2007 Oct;11(10):1261-71. 139. Tanaka H , Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest. 2002 May;121(5):1493-7. 140. Wacker, C, Med, C, Prkno, A. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet, 2013,13(5), 426-35. 223 141. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) Diagnostics guidance Published: 7 October 2015 nice.org.uk/guidance/dg18. 142. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34(7):1996-2003. 143. Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. International Journal of Antimicrobial Agents. 2002, 20: 1-9. 144. Becker KL, Nylen ES, White JC, et al: Procalcitonin and the calcitonin family of peptides in inflammation, infection and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-1525. 145. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J, and the Geneva Sepsis Network. Diagnostic Value of Procalcitonin, Interleukin-6 and Interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med.2001, 164: 396-402. 146. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998;(3):664-672. 147. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, De Curtis M. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;412(11-12):1053-1059. 148. Jacobs, DS, Oxley, DK, DeMott, WR (2004). Laboratory test handbook: Concise, with disease index (3rd ed.). Hudson (Cleveland), OH: Lexi-Comp. 149. Kumar, V, Abbas, AK, Aster, JC, Robbins, SL (2013). Robbins basic pathology (9th ed.). Philadelphia, PA: Elsevier/Saunders. 150. Lee JY, Hwang SJ, Shim JW, Jung HL, Park MS, Woo HY, Shim JY. Clinical Significance of Serum Procalcitonin on Patients with Community-acquired Lobar Pneumonia. Korean J Lab Med. 2010, 30(4): 406-13. 151. Pourakbari B, Mamishi S, Zafari J, Khairkhah H, Ashtiani MH, Abedini M, Afsharpaiman S, Rad SS. Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection. Braz J Infect Dis. 2010, 14(3): 252-255. 152. Sand M, Trullen XV, Bechara FG, Pala XF, Sand D, Landgrafe G and Mann B. A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis. 2009, 43: 291-297. 153. Summah H, Qu JM:Biomarkers. A definite plus in pneumonia. Mediators of inflammation.2009, ID 675753, 1-9. 154. Schultz MJ, Determann RM. PCT and sTREM-1: The markers of infection in critically ill patients? Med Sci Monit. 2008, 14(12): 241-247. 224 155. Arkader R, Troster EJ, Lopes MR, Júnior RR, Carcillo JA, Leone C, Okay TS. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child. 2006, 91: 117-120. 156. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacommuzzi F, Tenore A. Procalcitonin: A marker of severity of acute pyelonephritis among children. pediatrics. 2004, 114(2): 249-254. 157. Sitter T, Schmidt M, Schneider S, Schiffle H. Differential diagnosis of bacterial infection and inflammatory response in kidney disease using procalcitonin. J Nephrol 2002;15:297-301. 158. Woodworth, A. Procalcitonin: The Answer to the Sepsis Dilemma? - NACB Blog. https://www.aacc.org/members/nacb/NACBBlog/lists/posts/post.aspx?ID=16, 2014. 159. Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM: Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-623. 160. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220. 161. Tak W, Mak and Mary E. Saunders. (2006) The immune response, basic and clinical principles, pp. 484-486. Elsevier Academic Press, China. 162. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001 Jan 1;97(1):256-63. 163. Reikerås O, Helle A, Krohn CD, Brox JI. Systemic and local cytokine kinetics in musculoskeletal injury: a prospective study in patients with ankylosing spondylitis. Scand J Clin Lab Invest. 2009;69(2):198-203. 164. Neidhardt TR, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertrel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997;42:863-870. 165. Esmon CT. The interactions between inflammation and coagulation. HBr J Haematol.H 2005 Nov;131(4):417-430. 166. Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb).H 2012;22(1):49-62. 167. Edgcombe H, Carter K, Yarrow S. Anaesthesia in the prone position. Br J Anaesth. 2008 Feb;100(2):165-83. 168. Shukry M, D'Angelo JA, Joshi M, Cure JA, de Armendi AJ. Profound intraoperative metabolic acidosis and hypotension in a child undergoing multilevel spinal fusion. Case Rep Med. 2009;2009:190263. 169. Bain J Barbara, Bates Imelda, Laffan A Mike, Lewis S Mitchell. Dacie and Lewis Practical Haematology. Churchill Livingstone Elsevier, Health Sciences UK. 11th Ed. 2012. 225 170. Romih M, Delécrin J, Heymann D, Passuti N. The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow. Eur Spine J 2005 Sep;14(7):645-8. 171. Risbud MV, Shapiro IM, Guttapalli A, Di Martino A, Danielson KG, Beiner JM, Hillibrand A, Albert TJ, Anderson DG, Vaccaro AR. Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine (Phila Pa 1976) 2006 Jan 1;31(1):83-9. 172. Defino HL, da Silva Herrero CF, Crippa GE, Bellesini LS, Beloti MM, Rosa AL. In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest. Spine (Phila Pa 1976) 2009 Jul 1;34(15):1549-53. 173. Barbanti Brodano G, Terzi S, Trombi L, Griffoni C, Valtieri M, Boriani S, Magli MC. Mesenchymal stem cells derived from vertebrae (vMSCs) how best biological properties. Eur Spine J 2013 Nov;22 Suppl 6:S979-84. 174. Stem Cell Collection. Optimizing BM harvesting from normal adult donors. H Lannert, T Able, S Becker, M Sommer, M Braun, P Stadtherr, A D Ho. Bone Marrow Transplant. 2008; 42: 443–447. 175. Batinić D, Marusić M, Pavletić Z, Bogdanić V, Uzarević B, Nemet D, Labar B. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant. 1990 Aug;6(2):103-7. 176. Executive committee of the World Marrow Donor Association, Special report. Bone marrow transplants using volunteer donors - recommendations and requirements for a standardized practice throughout the world. Bone Marrow Transplant. 1992; 10: 287-291. 177. Muschler GF, Takigami H, Nakamoto C, Principles of bone fusion. The Spine, 5th edition, 1st volume; Rothman-Simeone, Saunders-Elsevier, Philadelphia. 2006, pp. 385-406. 178. J Davis, Basic Cell Culture: A Practical Approach. Oxford University Press, 2nd Ed., 2002. 179. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 180. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003 Jul 1;287(1):98-105. 181. Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, Kalbacher H, Bühring HJ. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev. 2013 Jul 1;22(13):1944-54. 182. Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L. Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue. Stem Cells Dev. 2015 Sep 15;24(18):2142-57. 226 183. Cuthbert RJ, Giannoudis PV, Wang XN, Nicholson L, Pawson D, Lubenko A, Tan HB, Dickinson A, McGonagle D, Jones E. Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration. PLoS One. 2015 Mar 11;10(3):e0117855. 184. Tomlinson MJ, Dennis C, Yang XB, Kirkham J. Tissue non-specific alkaline phosphatase production by human dental pulp stromal cells is enhanced by high density cell culture. Cell Tissue Res. 2015 Aug;361(2):529-40. 185. Kim YH, Yoon DS, Kim HO, Lee JW. Characterization of different subpopulations from bone marrow-derived mesenchymal stromal cells by alkaline phosphatase expression. Stem Cells Dev.2012 Nov 1;21(16):2958-68. 186. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012:975871. 187. Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A. 2014 Apr;20(7-8):1295-305. 188. Pippenger BE, Duhr R, Muraro MG, Pagenstert GI, Hügle T, Geurts J. Multicolour flow cytometry-based cellular phenotyping identifies osteoprogenitors and inflammatory cells in the osteoarthritic subchondral bone marrow compartment. Osteoarthritis Cartilage. 2015 Nov;23(11):1865-9. 189. Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y, Ohgushi H. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005 May-Jun;11(5-6):663-73. 190. Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods. 2012 Jun;18(6):453-63. 191. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012;2012:975871. 192. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999 Nov;265(1):134-9. 193. Boxall S, Jones E. The use of multiparameter flow cytometry and cell sorting to characterize native human bone marrow mesenchymal stem cells (MSC). Methods Mol Biol. 2015;1235:121-30. 194. Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun.2001 Nov 30;289(2):519-24. 195. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem. 2000 Mar 31;275(13):9645-52. 227 196. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004 Jun 1;329(1):77-84. 197. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol. 2011;698:253-78. 198. Temu TM, Wu KY, Gruppuso PA, Phornphutkul C. The mechanism of ascorbic acid-induced differentiation of ATDC5 chondrogenic cells. Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E325-34. 199. Tanaka H, Murphy CL, Murphy C, Kimura M, Kawai S, Polak JM. Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone. J Cell Biochem. 2004 Oct 15;93(3):454-62. 200. Cox G, Boxall SA, Giannoudis PV, Buckley CT, Roshdy T, Churchman SM, McGonagle D, Jones E. High abundance of CD271+ multipotential stromal cells (MSCs) in intramedullary cavities of long bones. Bone. 2012 Feb;50(2):510-7. 201. Baboolal TG, Boxall SA, Churchman SM, Buckley CT, Jones E, McGonagle D. Intrinsic multipotential mesenchymal stromal cell activity in gelatinous Heberden's nodes in osteoarthritis at clinical presentation. Arthritis Res Ther. 2014 Jun 3;16(3):R119. 202. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P, McGonagle D. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 2008 Jun;58(6):1731-40. 203. English A, Jones EA, Corscadden D, Henshaw K, Chapman T, Emery P, McGonagle D. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford). 2007 Nov;46(11):1676-83. 204. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 2004 Mar;50(3):817-27. 205. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol. 2011;698:253-78. 206. Keeney G, Leslie K. Preparing fresh tissues for the microscope. JAMA. 2008 Sep 3;300(9):1074-6. 207. Andrew H Fischer, Kenneth A Jacobson, Jack Rose, Rolf Zeller. Cryosectioning Tissues. This protocol was adapted from “Preparation of Cells and Tissues for Fluorescence Microscopy,” Chapter 4, Basic Methods in Microscopy (eds. Spector and Goldman). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2006. 208. Andrew H Fischer, Kenneth A Jacobson, Jack Rose, Rolf Zeller. Preparation of Slides and Coverslips for Microscopy. This protocol was adapted from “Preparation 228 of Cells and Tissues for Fluorescence Microscopy,” Chapter 4, Basic Methods in Microscopy (eds. Spector and Goldman). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2006. 209. Guo GH, Dong J, Yuan XH, Dong ZN, Tian YP. Clinical evaluation of the levels of 12 cytokines in serum/plasma under various storage conditions using evidence biochip arrays. Mol Med Rep. 2013 Mar;7(3):775-80. 210. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods. 1992 Aug 30;153(1-2):115-24. 211. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine. 2000 Nov;12(11):1712-6. 212. MRC Ethics Guide: Medical research involving children, Medical Research Council, 2004. 213. Catherine Shaw, Louca-Mai Brady and Ciara Davey. Guidelines for Research with Children and Young People. NCB Research Centre, 03/2011. 214. Kalton, G. Introduction to survey sampling. Newbury Park, CA: Sage, 1983. 215. Greene S, Hogan D. Researching children's experiences: methods and approaches. London: Sage, 1983. 216. Dal Pozzo S, Urbani S, Mazzanti B, Luciani P, Deledda C, Lombardini L, Benvenuti S, Peri A, Bosi A, Saccardi R. High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow. Cytotherapy 2010 Sep;12(5):579-86. 217. Bøyum, A. (1968) Separation of leucocytes from blood and bone marrow, Scand J Clin Lab Invest, 21, suppl.97. 218. Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology. 2015 Oct;71(2):181-97. 219. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 220. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003 Jul 1;287(1):98-105. 221. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy. 2001;3(5):393-6. 222. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-5. 229 223. Sarah Churchman and Elena Jones. The expression of novel mesenchymal/stromal lineage transcripts in uncultured CD271-positive MSCs: differences from culture-expanded MSCs. Excerpt from MACS & more Vol. 14 – 2/2012. 224. Wangen JR, Eidenschink Brodersen L, Stolk TT, Wells DA, Loken MR. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation. Int J Lab Hematol. 2014 Apr;36(2):184-96. 225. Jones E, Schäfer R. Biological differences between native and cultured mesenchymal stem cells: implications for therapies. Methods Mol Biol. 2015; 1235:105-20. 226. Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A. 2014 Apr;20(7-8):1295-305. 227. Aldridge A, Kouroupis D, Churchman S, English A, Ingham E, Jones E. Assay validation for the assessment of adipogenesis of multipotential stromal cells-a direct comparison of four different methods. Cytotherapy. 2013 Jan;15(1):89-101. 228. Naderi N, Wilde C, Haque T, Francis W, Seifalian AM, Thornton CA, Xia Z, Whitaker. Adipogenic differentiation of adipose-derived stem cells in 3-D spheroid cultures (microtissue): implications for the reconstructive surgeon. J Plast Reconstr Aesthet Surg. 2014 Dec;67(12):1726-34. 229. PA Fontes, C Ricordi, AS Rao, WB Rybka, SF Dodson, CG McAllister, B Broznick, FO Ukah, JJ Fung, TE Starzl. Human vertebral bodies as a source of bone marrow for cell augmentation in whole organ allografts Methods in Cell transplantation. ed: Camillo Ricordi. R.G. Landes Company 1994. Chapter H1:615-24. 230. Mansilla E, Mártire K, Roque G, Tau JM, Marín GH, Castuma MV, Orlandi G Tarditti A. Salvage of cadaver stem cells (CSCS) as a routine procedure: history or future for regenerative medicine. J. of Transplant Technol Res, 2013, 3:1. 231. Machalinski B, Kijowski J, Marlicz W, Gontarewicz A, Markiewski M, Paczkowski M, Kopkowski A, Majka M, Ostrowski M, Ratajczak MZ. Heparinized cadaveric organ donors (HCOD)-a potential source of hematopoietic cells for transplantation and gene therapy. Transplantation. 2001 Apr 15;71(7):1003-7. 232. Gambrall MA. Anaesthetic implications for surgical correction of scoliosis. AANA J. 2007 Aug;75(4):277-85. 233. Gessmann J, Köller M, Godry H, Schildhauer TA, Seybold D. Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia). 2012 Jan 2;4(1):e14. 234. Gigante A, Calcagno S, Cecconi S, Ramazzotti D, Manzotti S, Enea D. Use of collagen scaffold and autologous bone marrow concentrate as a one-step cartilage repair in the knee: histological results of second-look biopsies at 1 year follow-up. Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl 2):69-72. 230 235. Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA, Zimmermann G, Luginbühl R. Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur Cell Mater. 2008 Oct 23;16:47-55. 236. Kroschinsky F, Kittner T, Mauersberger S, Rautenberg U, Schuler U, Rutt C, Laniado M, Ehninger G. Pelvic magnetic resonance imaging after bone marrow harvest- retrospective study in 50 unrelated marrow donors. Bone Marrow Transplant. 2005 Apr;35(7):667-73. 237. Ortiz SS, Miller JH, Villablanca JG, Seeger RC. Bone abnormalities detected with skeletal scintigraphy after bone marrow harvest in patients with childhood neuroblastoma. Radiology. 1994 Sep;192(3):755-8. 238. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age related Osteogenic potential of Mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999 Jul;14(7):1115-22. 239. Friebert SE, Shepardson LB, Shurin SB, Rosenthal GE, Rosenthal NS. Pediatric bone marrow cellularity: are we expecting too much? J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):439-43. 240. Zhou Z, Jiang EL, Wang M, Liu QG, Zhai WJ, Huang Y, Wang HH, Han MZ Zhongguo. Comparative study on various subpopulations in mesenchymal stem cells of adult bone marrow. Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):54-8. 241. Kaltz N, Ringe J, Holzwarth C, Charbord P, Niemeyer M, Jacobs VR, Peschel C, Häupl T, Oostendorp RA. Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res. 2010 Oct 1;316(16):2609-17. 242. Elena Jones, Richard Schäfer. Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species? Stem Cell Res Ther. 2015; 6(1): 143. 243. Panepucci RA, Siufi JL, Silva WA Jr, Proto-Siquiera R, Neder L, Orellana M, Rocha V, Covas DT, Zago MA. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004;22(7):1263-78. 244. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006 Jun 1;119(Pt 11):2204-13. 245. Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J 2012 Oct 16;2(3):154-62. 246. Narbona-Carceles J, Vaquero J, Suárez-Sancho S, Forriol F, Fernández-Santos ME. Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest? Injury. 2014 Oct;45 Suppl 4:S42-7. 247. Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011 Feb;12(2):126-31. 248. Ackema KB, Charité J. Mesenchymal stem cells from different organs are characterized by distinct topographic Hox codes. Stem Cells Dev. 2008 Oct;17(5):979-91. 231 249. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec;46(12):3349-60. 250. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001 Jan;19(1):117-25. 251. Liu H, Toh WS, Lu K, MacAry PA, Kemeny DM, Cao T.A subpopulation of mesenchymal stromal cells with high osteogenic potential. J Cell Mol Med. 2009 Aug;13(8B):2436-47. 252. Ardeshirylajimi A, Soleimani M, Hosseinkhani S, Parivar K, Yaghmaei P.A comparative study of osteogenic differentiation human induced pluripotent stem cells and adipose tissue derived mesenchymal stem cells. Cell J. 2014 Fall;16(3):235-44. 253. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol. 2008;40(1):46-62. 254. A Rawls, RE Fisher. Development and Functional Anatomy of the Spine. The Genetics and Development of Scoliosis, Kusumi, S.L. Dunwoodie (eds.) C Springer Science Business Media 2010, Chapter 2: 21-46. 255. De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003 Mar 17;160(6):909-18. 256. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, Baggett LS, Mikos AG, Cao Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 2008 Oct 28;9:60. 257. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC.In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells.2010 Apr;28(4):788-98. 258. Gambrall MA. Anaesthetic implications for surgical correction of scoliosis. AANA J. 2007 Aug;75(4):277-85. 259. J. Matthew Kynes, Faye M. Evans. Surgical correction of scoliosis anaesthetic considerations. ATOTW 318, 10th July 2015. 260. Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty. 2016 Nov;31(11):2458-2464. 261. Takahashi J, Ebara S, Kamimura M, Kinoshita T, Misawa H, Shimogata M, Tozuka M, Takaoka K. Pro-inflammatory and anti-inflammatory cytokine increases after spinal instrumentation surgery. J Spinal Disord Tech. 2002 Aug;15(4):294-300. 262. Bosch P, Kenkre TS, Londino JA, Cassara A, Yang C, Waters JH. Coagulation Profile of Patients with Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion. J Bone Joint Surg Am. 2016 Oct 19;98(20):e88. 232 263. Ono S, Tsujimoto H, Hiraki S, Takahata R, Kinoshita M, Mochizuki H. Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery. Am J Surg 2005;190:439-444. 264. Sperry JL, Friese RS, Frankel HL, West MA, Cuschieri J, Moore EE, Harbrecht BG, Peitzman AB, Billiar TR, Maier RV, Remick DG, Minei JP; Inflammation and the Host Response to Injury Investigators. Male gender is associated with excessive IL-6 expression following severe injury. J Trauma. 2008 Mar;64(3):572-8. 265. Yeon Gu Chung, Yu Sam Won, Young Joon Kwon, Hyun Chul Shin, Chun Sik Choi, Joon-Sup Yeom. Comparison of Serum CRP and Procalcitonin in Patients after Spine Surgery. J Korean Neurosurg Soc. 2011 Jan; 49(1): 43–48. 266. Smith RM, Giannoudis PV, Bellamy MC, Perry SL, Dickson RA, Guillou PJ. Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing. Clin Orthop Relat Res. 2000 Apr;(373):233-40. 267. Peronnet E, Nguyen K, Cerrato E, Guhadasan R , Venet F, Textoris J, Pachot A, Monneret G, Carrol ED. Evaluation of mRNA Biomarkers to Identify Risk of Hospital Acquired Infections in Children Admitted to Paediatric Intensive Care Unit. PLoS One. 2016 Mar 25;11(3):e0152388. 268. de Almeida DC, Ferreira MR, Franzen J, Weidner CI, Frobel J, Zenke M, Costa IG, Wagner W. Epigenetic Classification of Human Mesenchymal Stromal Cells. Stem Cell Reports, 2016. 6(2): p. 168-75. 269. Brief report: Group 3 Innate Lymphoid Cells in Human Enthesis. Cuthbert RJ, Fragkakis EM, Dunsmuir R, Li Z, Coles M, Marzo-Ortega H, Giannoudis PV, Jones E, El-Sherbiny YM, McGonagle D. Arthritis Rheumatol. sep. 2017."]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["M.D"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["uk.bl.ethos.729432"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://etheses.whiterose.ac.uk/id/eprint/18878/1/THESIS%20E%20M%20Fragkakis%2C%209-11-17.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In patients undergoing adolescent idiopathic scoliosis (AIS) surgery the yield and differentiation capacities of mesenchymal stem cells (MSCs) from vertebral body (VB) and iliac crest (IC) bone marrow (BM) were investigated comparing the effectiveness of two MSC-harvesting procedures [density gradient centrifugation (Lymphoprep, LMP) and red cell lysis (Ammonium Chloride, AC)]. The burden of surgery of 3 surgical approaches (posterior, posterior-costoplasty, antero-posterior), for AIS correction was also quantified. In 18 patients 10ml of BM were aspirated intraoperatively from IC and VB and MSCs were isolated using AC and LMP harvesting procedures. MSCs were enumerated and phenotypically characterised using colony-forming-unit-fibroblast (CFU-F), flow cytometry and trilineage differentiation assays. For the immuno-inflammatory study 23 patients were recruited. ELISA-assays were performed on serum from 4ml of peripheral blood, at 6 peri-operative time-points (T), measuring 4 cytokines [(Interleukin) IL-6, IL-10, IL-18 and Procalcitonin (PCT)]. Surgical parameters and gender variability were also analysed. Both IC and VB exhibited similar concentrations of MSCs, however AC yielded significantly more MSC/ml by 1.8-fold (IC, p=0.012) and 1.5-fold (VB, p=0.043), compared to LMP. Calcium and glycosaminoglycan (GAG) concentrations were both significantly higher from VB MSCs, compared to IC [Calcium: AC 8.7-fold (p=0.001), LMP 1.2-fold, GAG: AC 3.8-fold (p=0.0005), LMP 1.9-fold (p=0.003)]. Adipogenesis did not show significant differences. VB AC-harvested MSCs presented a significantly smaller colony area by 1.9-fold (p=0.039), compared to IC AC. The post-operative concentrations of IL-6 and IL-10 were always significatintly elevated at T2 and T3 points, in all 3 approaches (p<0.01) with antero-posterior approach presenting the highest levels followed by posterior-costoplasty and posterior approaches. Although prolonged procedures and gender type affected cytokine concentrations, their levels were not statistically significant. In summary, AC isolated more effectively MSCs, without affecting their function. VBBM MSCs demonstrated higher osteo- and chondro-genic differentiation capacities, representing a valid source of MSCs in spinal surgery. The surgical stress reaction quantified with immune-inflammatory markers, was higher in more aggressive and extensile procedures, suggesting greater vigilance in identifying and preventing complications."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Characterisation of the immuno-inflammatory response following operative adolescent idiopathic scoliosis and biological properties of osteoprogenitor cells harvested from vertebral bodies compared to iliac crest."]}]}],"canonical_facts":{"dc:contributor.advisor":["Giannoudis, Gianoudis, Peter V (40% supervision)","Jones, Jones Elena (40% supervision)","Pountos, Pountos Ippokratis (20% supervision)"],"dc:contributor.sponsor":["Italian Society Of Trauma and Orthopaedics (SIOT)","Yorkshire Children's Spine Foundation"],"dc:creator":["Fragkakis, Evangelos Minas"],"dc:date":["2016-11"],"dc:date.issued":["2016-11"],"dc:description.abstract":["In patients undergoing adolescent idiopathic scoliosis (AIS) surgery the yield and differentiation capacities of mesenchymal stem cells (MSCs) from vertebral body (VB) and iliac crest (IC) bone marrow (BM) were investigated comparing the effectiveness of two MSC-harvesting procedures [density gradient centrifugation (Lymphoprep, LMP) and red cell lysis (Ammonium Chloride, AC)]. The burden of surgery of 3 surgical approaches (posterior, posterior-costoplasty, antero-posterior), for AIS correction was also quantified. In 18 patients 10ml of BM were aspirated intraoperatively from IC and VB and MSCs were isolated using AC and LMP harvesting procedures. MSCs were enumerated and phenotypically characterised using colony-forming-unit-fibroblast (CFU-F), flow cytometry and trilineage differentiation assays. For the immuno-inflammatory study 23 patients were recruited. ELISA-assays were performed on serum from 4ml of peripheral blood, at 6 peri-operative time-points (T), measuring 4 cytokines [(Interleukin) IL-6, IL-10, IL-18 and Procalcitonin (PCT)]. Surgical parameters and gender variability were also analysed. Both IC and VB exhibited similar concentrations of MSCs, however AC yielded significantly more MSC/ml by 1.8-fold (IC, p=0.012) and 1.5-fold (VB, p=0.043), compared to LMP. Calcium and glycosaminoglycan (GAG) concentrations were both significantly higher from VB MSCs, compared to IC [Calcium: AC 8.7-fold (p=0.001), LMP 1.2-fold, GAG: AC 3.8-fold (p=0.0005), LMP 1.9-fold (p=0.003)]. Adipogenesis did not show significant differences. VB AC-harvested MSCs presented a significantly smaller colony area by 1.9-fold (p=0.039), compared to IC AC. The post-operative concentrations of IL-6 and IL-10 were always significatintly elevated at T2 and T3 points, in all 3 approaches (p<0.01) with antero-posterior approach presenting the highest levels followed by posterior-costoplasty and posterior approaches. Although prolonged procedures and gender type affected cytokine concentrations, their levels were not statistically significant. In summary, AC isolated more effectively MSCs, without affecting their function. VBBM MSCs demonstrated higher osteo- and chondro-genic differentiation capacities, representing a valid source of MSCs in spinal surgery. The surgical stress reaction quantified with immune-inflammatory markers, was higher in more aggressive and extensile procedures, suggesting greater vigilance in identifying and preventing complications."],"dc:format":["text"],"dc:identifier":["uk.bl.ethos.729432"],"dc:identifier.uri":["https://etheses.whiterose.ac.uk/id/eprint/18878/1/THESIS%20E%20M%20Fragkakis%2C%209-11-17.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.commercial":["University of Leeds"],"dc:publisher.department":["Section of Musculoskeletal Disease (Leeds)","Faculty of Medicine and Health (Leeds)"],"dc:publisher.institution":["University of Leeds"],"dc:relation.isreferencedby":["https://etheses.whiterose.ac.uk/id/eprint/18878/"],"dc:relation.references":["1. Rothman-Simeone. The Spine, Saunders 5th edition 2006, 1st volume, Idiopathic scoliosis, chap:33, 515-534. 2. Divecha HM, Siddique I, Breakwell LM, Millner PA. British Scoliosis Society Members. Complications in spinal deformity surgery in the United Kingdom: 5-year results of the annual British Scoliosis Society National Audit of Morbidity and Mortality. 2014 Apr; 23 Suppl 1:S55-60. 3. Lenke LG, Betz RR, Harms f, Bridwell KH, Clements DH, Lowe TG, Blanke K. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthrodesis. The journal of bone and joint surgery American volume, 2001 Aug;83 -A,B: 1, 169-81. 4. Kal Kaur. Stainless Steel and Titanium in Surgical Implants. AZojomo, Sep 26, 2012. 5. Gail K Smith. Orthopaedic biomaterials, chapter 13, \"Textbook of Small Animal Orthopaedics\" Charles D. Newton, D.V.M., M.S., David M. Nunamaker, V.M.D. Publ: J.B. Lippincott Company, 1985. 6. Reames DL, Smith JS, Fu KM, Polly DW Jr, Ames CP, Berven SH, Perra JH, Glassman SD, McCarthy RE, Knapp RD Jr, Heary R, Shaffrey Cl. Scoliosis Research Society Morbidity and Mortality Committee. Complications in the surgical treatment of 19,360 cases of paediatric scoliosis: a review of the Scoliosis Research Society Morbidity and Mortality database. Spine (Phila Pa 1976), 2011, Aug 15;36(18):1484-91. 7. Robert F Mclain, James E Fleming, Cynthia A Boehm, George F Muschler. Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005 December; 87(12): 2655–2661. 8. Kim DH, Rhim R, Li L, Martha J, Swaim BH, Banco RJ, Jenis LG, Tromanhauser SG. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009 Nov;9(11):886-92. 9. Cahill KS, McCormick PC, Levi AD. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis. J Neurosurg Spine. 2015 Jul;23(1):86-93. 10. Hustedt JW, Blizzard DJ. The controversy surrounding bone morphogenetic proteins in the spine: a review of current research. Yale J Biol Med. 2014 Dec 12;87(4):549-61. 11. Vaccaro AR, Stubbs HA, Block JE. Demineralized bone matrix composite grafting for posterolateral spinal fusion. Orthopedics. 2007 Jul;30(7):567-70. 12. Kang J, An H, Hilibrand A, Yoon ST, Kavanagh E, Boden S. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions. Spine (Phila Pa 1976). 2012 May 20;37(12):1083-91. 214 13. Jäger M, Hernigou P, Zilkens C, Herten M, Li X, Fischer J, Krauspe R. Cell therapy in bone healing disorders. Orthop Rev (Pavia). 2010 Sep 23;2(2):e20. 14. Ugo Del Torto. Lezioni di clinica ortopedica. Italian Ed;8, Piccin, 1990. 15. Schünke, Schulte, Schumacher, Voll, Wesker. Prometheus, Texto y atlas de anatomìa, Tomo 1. Spanish Ed;2, Panamericana, 2011. 16. Attilio Mancini, Carlo Morlacchi. Clinica ortopedica, Manuale-atlante. Italian Ed;4, Piccin, 2003. 17. Thomas P R edi, Richard E Buckley, Christopher G Morgan. AO principles of fracture management, Vol. 1. Ed. 2, Davos : AO Publishing, 2007. 18. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005 Dec;36(12):1392-404. 19. Marsell R, Einhorn TA. The biology of fracture healing. Injury, 2011 Jun;42(6):551-5. 20. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003 Apr 1;88(5):873-84. 21. Marsell R, Einhorn TA The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 2009 Dec;40 Suppl 3:S4-7. 22. Fayaz HC, Giannoudis PV, Vrahas MS, Smith RM, Moran C, Pape HC, Krettek C, Jupiter JB. The role of stem cells in fracture healing and nonunion. Int Orthop. 2011 Nov;35(11):1587-97. 23. Ravindra VM, Godzik J, Dailey AT, Schmidt MH, Bisson EF, Hood RS, Cutler A, Ray WZ. Vitamin D Levels and 1-Year Fusion Outcomes in Elective Spine Surgery: A Prospective Observational Study. Spine (Phila Pa 1976). 2015 Oct 1;40(19):1536-41. 24. Adams CI, Keating JF, Court-Brown CM. Cigarette smoking and open tibial fractures. Injury. 2001 Jan;32(1):61-5. 25. Hoogduijn MJ, Cheng A, Genever PG. Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev. 2009 Jan-Feb;18(1):103-12. 26. Brown CW, Orme TJ, Richardson HD. The rate of pseudoarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: a comparison study. Spine (Phila Pa 1976). 1986 Nov;11(9):942-3. 27. Hermann PC, Webler M, Bornemann R, Jansen TR, Rommelspacher Y, Sander K, Roessler PP, Frey SP, Pflugmacher R. Influence of smoking on spinal fusion after spondylodesis surgery: A comparative clinical study. Technol Health Care. 2016 Apr 21. 28. Laytragoon-Lewin N, Bahram F, Rutqvist LE, Turesson I, Lewin F. Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. Anticancer Res. 2011 May;31(5):1527-34. 215 29. Einhorn TA, Bonnarens F, Burstein AH. The contributions of dietary protein and mineral to the healing of experimental fractures. A biomechanical study. J Bone Joint Surg Am. 1986 Dec;68(9):1389-95. 30. Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012 Mar;73(3):348-62. 31. Tétrault M, Courtois F. Use of psychoactive substances in persons with spinal cord injury: a literature review. Ann Phys Rehabil Med. 2014 Dec;57(9-10):684-95. 32. Ronis MJ, Mercer K, Chen JR. Effects of nutrition and alcohol consumption on bone loss. Curr Osteoporos Rep. 2011 Jun;9(2):53-9. 33. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br. 2000 Jul;82(5):655-8. 34. Kameda H, Amano K, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Suzuki K, Takeuchi T. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. Intern Med. 2009;48(22):1931-8. Epub 2009 Nov 16. 35. Boursinos LA, Karachalios T, Poultsides L, Malizos KN. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing? J Musculoskelet Neuronal Interact.2009 Jan-Mar;9(1):44-52. 36. Martín-Esteve I, Aparicio-Espinar M, Hernández-Gañan J, Narváez J. Vertebral osteonecrosis as a complication of corticosteroid therapy: the intravertebral vacuum cleft sign. Reumatol Clin. 2012 Nov-Dec;8(6):375-7. 37. LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM, Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM, Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Rauch F, Siminoski K, Ward LM; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Paediatric Patients With Rheumatic Disorders. J Bone Miner Res. 2015 Sep;30(9):1667-75. 38. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007 Sep;38 Suppl 4:S3-6. 39. Tannoury CA, An HS. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J. 2014 Mar 1;14(3):552-9. 40. Dimitriou R, Carr IM, West RM, Markham AF, Giannoudis PV. Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway. BMC Musculoskelet Disord. 2011 Feb 10;12:44. 41. Hangama C. Fayaz, Peter V. Giannoudis, Mark S. Vrahas, Raymond Malcolm Smith, Christopher Moran, Hans Christoph Pape, Christian Krettek, Jesse B. Jupiter. The role of stem cells in fracture healing and nonunion. 8 Int Orthop. 2011 Nov; 35(11): 1587–1597. 216 42. Stewart Sell, Stem cells handbook. Ch: 10., Humana Press Inc. Totowa, New Jersey, 2004. 43. Elena Jones, Xuebin Yang, Peter Giannoudis, Dennis McGonagle. Mesenchymal Stem Cells and Skeletal Regeneration. Academic Press; ed. 1, 20 Feb 2013. 44. Becker AJ, McCulloch EA, Till JE. Pillars article: Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963. 197:452-454. J Immunol. 2014 Jun 1;192(11):4945-7. 45. Huang S, Leung V, Peng S, Li L, Lu FJ, Wang T, Lu W, Cheung KM, Zhou G. Developmental definition of MSCs: new insights into pending questions. Cell Reprogram. 2011 Dec;13(6):465-72. 46. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006 Apr;54(4):1209-21. 47. De Bari C, Dell'Accio F, Karystinou A, Guillot PV, Fisk NM, Jones EA, McGonagle D, Khan IM, Archer CW, Mitsiadis TA, Donaldson AN, Luyten FP, Pitzalis C. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 2008 Jan;58(1):240-50. 48. Dennis JE, Carbillet JP, Caplan AI, Charbord P.The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs. 2002;170(2-3):73-82. 49. Hernigou P, Homma Y, Flouzat Lachaniette CH, Poignard A, Allain J, Chevallier N, Rouard H. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop. 2013 Nov;37(11):2279-87. 50. Kitchel SH, Wang MY, Lauryssen CL. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 2005 Oct;57(4 Suppl):286-9; discussion 286-9. 51. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 1997 Nov;79(11):1699-709. 52. McLain RF, Boehm CA, Rufo-Smith C, Muschler GF. Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J 2009 Dec;9(12):995-1002. 53. Hustedt JW, Jegede KA, Badrinath R, Bohl DD, Blizzard DJ. Optimal aspiration volume of vertebral bone marrow for use in spinal fusion. Grauer JN.Spine J. 2013 Oct;13(10):1217-22. 54. Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, Wagner W. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy 2008;10(7):676-85. 55. Carrancio S, López-Holgado N, Sánchez-Guijo FM, Villarón E, Barbado V, Tabera S, Díez-Campelo M, Blanco J, San Miguel JF, Del Cañizo MC. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008 Aug;36(8):1014-21. 217 56. Ahmadbeigi N, Soleimani M, Babaeijandaghi F, Mortazavi Y, Gheisari Y, Vasei M, Azadmanesh K, Rostami S, Shafiee A, Nardi NB. The aggregate nature of human mesenchymal stromal cells in native bone marrow. Cytotherapy. 2012 Sep;14 (8):917-24. 57. Horn P, Bork S, Wagner W. Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. Methods Mol Biol 2011;698:23-35. 58. Soukup T, Mokrý J, Karbanová J, Pytlík R, Suchomel P, Kucerová L. Mesenchymal stem cells isolated from the human bone marrow: cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Medica (Hradec Kralove) 2006;49(1):27-33. 59. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 60. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec;46(12):3349-60. 61. Hernigou P, Flouzat Lachaniette CH, Delambre J, Chevallier N, Rouard H. Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence? Int Orthop. 2014 Sep;38(9):1825-35. 62. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, Neumann U, Scheding S. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 2004 Sep 27;78(6):925-9. 63. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol. 2008;52(8):1023-32. 64. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 2008 Feb;58(2):501-10. 65. Bridget M. Deasy, Jordan E. Anderson, Shannon Zelina Regulatory Issues in the Therapeutic Use of Stem Cells, Regenerative Medicine and Tissue Engineering, ch.9, 2013. 66. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996 Aug;(329):300-309. 67. Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech. 2005 Feb;18 Suppl:S77-81. 68. Woo-Kie Min, Jae-Sung Bae, Byung-Chul Park, In-Ho Jeon, Hee Kyung Jin, Min-Jung Son, Eui Kyun Park, Shin-Yoon Kim. Proliferation and osteoblastic differentiation of bone marrow stem cells: comparison of vertebral body and iliac crest. Eur Spine J (2010) 19:1753–1760. 218 69. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. 70. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005 Jul;87(7):896-902. 71. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005 Jul;87(7):1430-7. 72. Ruetze M, Richter W. Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity. Expert Rev Mol Med. 2014 May 9;16:e9. 73. Braem K, Lories RJ. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine. 2012 May;79(3):243-8. 74. Giannoudis PV, Pountos I. Tissue regeneration. The past, the present and the future. Injury. 2005 Nov;36 Suppl 4:S2-5. 75. Kouroupis D, Baboolal TG, Jones E, Giannoudis PV. Native multipotential stromal cell colonization and graft expander potential of a bovine natural bone scaffold. J Orthop Res 2013 Dec;31(12):1950-8. 76. Vieira MH, Oliveira RJ, Eça LP, Pereira IS, Hermeto LC, Matuo R, Fernandes WS, Silva RA, Antoniolli AC. Therapeutic potential of mesenchymal stem cells to treat Achilles tendon injuries. Genet Mol Res. 2014 Dec 12;13(4):10434-49. 77. Levy M, Boulis N, Rao M, Svendsen CN. Regenerative cellular therapies for neurologic diseases. Brain Res. 2016 May 1;1638(Pt A):88-96. 78. Ringe J, Sittinger M. Tissue engineering in the rheumatic diseases. Arthritis Res Ther 2009;11(1):211. 79. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M.Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006 Jan;24(1):74-85. Epub 2005 Aug 11. 80. Raynaud CM, Yacoub MH. Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? Time, Swiss-Ami, Cellwave, Poseidon And C-Cure. Glob Cardiol Sci Pract. 2013 Nov 1;2013(3):207-11. 2013. 81. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000 Feb;127(2):117-26. 82. Giannoudis PV, Smith RM, Bellamy MC, Morrison JF, Dickson RA, Guillou PJ. Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures; an analysis of the second hit. Journal Bone Joint Surgery (Br) 1999;81:356-361. 83. Giannoudis PV, Smith RM, Bellamy MC, Dickson RA, Guillou PJ. Immune reactivity following stabilisation of femoral fractures: A prospective study assessing the release of molecular mediators. Shock 2000;13:138-139. 219 84. Giannoudis PV. Surgical priorities in damage control in polytrauma. J Bone Joint Surg Br 2003;85:478-83. 85. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury 2003;34:397-404. 86. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med 1996;24:162-172. 87. Giannoudis PV, Smith PM, Ramsden CW. Molecular mediators and trauma: effects of accidental trauma on the production of plasma elastase, IL-6, ICAM-1 and E-selectin. Injury 1996;27:376-377. 88. Giannoudis PV Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 2004 ;86:313-323. 89. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990;Apr;170(4):363-378. 90. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 1990;73:308-327. 91. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury 2007 Dec;38(12):1358-64. 92. Blauth M, Knop C, Bastian L, Krettek C, Lange U. Complex injuries of the spine. Orthopade. 1998 Jan;27(1):17-31. 93. Waydhas C, Nast-Kolb D, Kick M, Richter-Turtur M, Trupka A, Machleidt W, Jochum M, Schweiberer L. Operative injury in spinal surgery in the management of polytrauma patients. Unfallchirurg. 1993 Feb;96(2):62-5. 94. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosup- pression? Langenbecks Arch Surg. 2004 Nov;389(6):475-84. 95. DeLong WG Jr, Born CT. Cytokines in patients with polytrauma. Clin Orthop Relat Res. 2004 May;(422):57-65. 96. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006 Nov;141(11):1132-40. 97. Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Büller HR, Hoek FJ, Horikx J, ten Cate JW. Interleukin-6 mediates host defence responses induced by abdominal surgery. Surgery 1993 Sep;114:56&70. 98. Weiss HR, Godall D. Rate of complications in scoliosis surgery-a systematic review of the Pub Med literature. Scoliosis. 2008 Aug 5;3:9. 99. Suzuki N, Kaneko O, Nakayama T, Fukuiya Y, Kuge S, Fujimura Y. Immunological suppression after surgery in scoliosis patients. Eur Spine J. 1997;6(1):39-44. 220 100. Krohn CD, Reikerås O, Aasen AO. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL-10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg. 1999 Feb;165(2):101-9. 101. Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ, Luo ZJ. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013 May 15;6(6):1009-14. 102. Krohn CD, Reikerås O, Aasen AO. Inflammatory cytokines and their receptors in arterial and mixed venous blood before, during and after infusion of drained untreated blood. Transfus Med. 1999 Jun;9(2):125-30. 103. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine (Phila Pa 1976) 2002 Jul 1;27(13):1402-7. 104. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 1996 Feb 1;21(3):271-7. 105. Andrade P, Hoogland G, Garcia MA, Steinbusch HW, Daemen MA, Visser-Vandewalle V. Elevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J. 2013 Apr;22(4):714-20. 106. Ohtori S, Inoue G, Eguchi Y, Orita S, Takaso M, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Sakuma Y, Oikawa Y, Kubota G, Inage K, Sainoh T, Toyone T, Yamauchi K, Kotani T, Akazawa T, Minami S, Takahashi K. Tumor necrosis factor-α immunoreactive cells in nucleus pulposus in adolescent patients with lumbar disc herniation. Spine (Phila Pa 1976). 2013 Mar 15;38(6):459-62. 107. Andrade P, Visser-Vandewalle V, Philippens M, Daemen MA, Steinbusch HW, Buurman WA, Hoogland G. Tumor necrosis factor-α levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between tumor necrosis factor receptor 1 and 2. Pain 2011 Nov;152(11):2645-52. 108. Tak W, Mak and Mary E. Saunders. (2006) The immune response, basic and clinical principles, pp. 481-482. Elsevier Academic Press, China. 109. Giannoudis PV, Smith RM, Perry SL, Windsor AJ, Dickson RA, Bellamy MC. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 2000; Aug;26(8):1076-1081. 110. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World Journal Surgery 1992;5:16-30. 111. Collighan N, Giannoudis PV, Kourgeraki O, Perry SL, Guillou PJ, Bellamy MC. Interleukin 13 and inflammatory markers in human sepsis. Br J Surg 2004 ;91:762-768. 221 112. Hildebrand F, van Griensven M, Giannoudis P, Luerig A, Harwood P, Harms O, Fehr M, Krettek C, Pape HC. Effects of hypothermia and re-warming on the inflammatory response in a murine multiple hit model of trauma. Cytokine 2005 Sep 7;31(5):382-393. 113. Charles A. Dinarello. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011 April 7; 117(14): 3720–3732. 114. H Dinarello CA. Interleukin-1, interleukin-1-receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16(5-6):457-499. 115. Borish LC, HSteinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003 Feb;111(2 Suppl):S460-475. 116. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury 2007 Sep;38 Suppl 4:S23-33. 117. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000 Aug;28(8):875-84. 118. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012;2012:975871. 119. Hildebrand F, Pape HC, Krettek C. The importance of cytokines in the post-traumatic inflammatory reaction. Unfallchirurg. 2005 Oct;108(10):793-4, 796-803. 120. Dinarello CA. Pro-inflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997 Dec;112(6 Suppl.):321S-329S. 121. Ogawa M. Mechanisms of the development of organ failure following surgical insult: the “second attack theory.” Clin Intensive Care 1996;7:34-38. 122. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998;17(1-4):1-52. 123. Tak W, Mak and Mary E. Saunders.(2006) The immune response, basic and clinical principles, pp. 486-487. Elsevier Academic Press, China. 124. Hart PH, Bonder CS, Balogh J, Dickensheets HL, Donnelly RP, Finlay-Jones JJ. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol. 1999 Oct;66(4):575-578. 125. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000 Apr 18;101(15):1767-72. 126. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005 Apr;98(4):1154-62. 127. Alecu M, Geleriu L, Coman G, Gălăţescu L. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis. Rom J Intern Med. 1998 Jul-Dec;36(3-4):251-9. 222 128. Nikolova S, Dikova M, Dikov D, Djerov A, Dzhebir G, Atanasov V, Savov A, Kremensky I. Role of the IL-6 gene in the etiopathogenesis of idiopathic scoliosis. Anal Cell Pathol (Amst). 2015;2015:621893. 129. Mórocz M, Czibula A, Grózer ZB, Szécsényi A, Almos PZ, Raskó I, Illés T. Association study of BMP4, IL-6, Leptin, MMP3, and MTNR1B gene promoter polymorphisms and adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2011 Jan 15;36(2):E123-30. 130. Aulisa L, Papaleo P, Pola E, Angelini F, Aulisa AG, Tamburrelli FC, Pola P, Logroscino CA. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study. Spine (Phila Pa 1976). 2007 Nov 15;32(24):2700-2. 131. Lee JS, Suh KT, Eun IS. Polymorphism in interleukin-6 gene is associated with bone mineral density in patients with adolescent idiopathic scoliosis. J Bone Joint Surg Br. 2010 Aug;92(8):1118-22. 132. Liu Z, Tang NL, Cao XB, Liu WJ, Qiu XS, Cheng JC, Qiu Y. Lack of association between the promoter polymorphisms of MMP-3 and IL-6 genes and adolescent idiopathic scoliosis: a case-control study in a Chinese Han population. Spine (Phila Pa 1976). 2010 Aug 15;35(18):1701-5. 133. Dinarello CA, Novick D, Rubinstein M, Lonnemann G. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure. Blood Purif. 2003;21(3):258-70. 134. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukuda Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T-cells. Nature 1995;378:88-91. 135. Dinarello CA, Fantuzzi G. Interleukin-18 and host defence against infection. J Infect Dis. 2003 Jun 15;187 Suppl 2:S370-84. 136. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol. 2000 Nov;7(6):909-14. 137. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W. Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 2001;16:411-414. 138. Yuan BS, Zhu RM, Braddock M, Zhang XH, Shi W, Zheng MH.Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis. Expert Opin Ther Targets. 2007 Oct;11(10):1261-71. 139. Tanaka H , Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest. 2002 May;121(5):1493-7. 140. Wacker, C, Med, C, Prkno, A. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet, 2013,13(5), 426-35. 223 141. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) Diagnostics guidance Published: 7 October 2015 nice.org.uk/guidance/dg18. 142. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34(7):1996-2003. 143. Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. International Journal of Antimicrobial Agents. 2002, 20: 1-9. 144. Becker KL, Nylen ES, White JC, et al: Procalcitonin and the calcitonin family of peptides in inflammation, infection and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-1525. 145. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J, and the Geneva Sepsis Network. Diagnostic Value of Procalcitonin, Interleukin-6 and Interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med.2001, 164: 396-402. 146. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998;(3):664-672. 147. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, De Curtis M. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;412(11-12):1053-1059. 148. Jacobs, DS, Oxley, DK, DeMott, WR (2004). Laboratory test handbook: Concise, with disease index (3rd ed.). Hudson (Cleveland), OH: Lexi-Comp. 149. Kumar, V, Abbas, AK, Aster, JC, Robbins, SL (2013). Robbins basic pathology (9th ed.). Philadelphia, PA: Elsevier/Saunders. 150. Lee JY, Hwang SJ, Shim JW, Jung HL, Park MS, Woo HY, Shim JY. Clinical Significance of Serum Procalcitonin on Patients with Community-acquired Lobar Pneumonia. Korean J Lab Med. 2010, 30(4): 406-13. 151. Pourakbari B, Mamishi S, Zafari J, Khairkhah H, Ashtiani MH, Abedini M, Afsharpaiman S, Rad SS. Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection. Braz J Infect Dis. 2010, 14(3): 252-255. 152. Sand M, Trullen XV, Bechara FG, Pala XF, Sand D, Landgrafe G and Mann B. A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis. 2009, 43: 291-297. 153. Summah H, Qu JM:Biomarkers. A definite plus in pneumonia. Mediators of inflammation.2009, ID 675753, 1-9. 154. Schultz MJ, Determann RM. PCT and sTREM-1: The markers of infection in critically ill patients? Med Sci Monit. 2008, 14(12): 241-247. 224 155. Arkader R, Troster EJ, Lopes MR, Júnior RR, Carcillo JA, Leone C, Okay TS. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child. 2006, 91: 117-120. 156. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacommuzzi F, Tenore A. Procalcitonin: A marker of severity of acute pyelonephritis among children. pediatrics. 2004, 114(2): 249-254. 157. Sitter T, Schmidt M, Schneider S, Schiffle H. Differential diagnosis of bacterial infection and inflammatory response in kidney disease using procalcitonin. J Nephrol 2002;15:297-301. 158. Woodworth, A. Procalcitonin: The Answer to the Sepsis Dilemma? - NACB Blog. https://www.aacc.org/members/nacb/NACBBlog/lists/posts/post.aspx?ID=16, 2014. 159. Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM: Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-623. 160. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220. 161. Tak W, Mak and Mary E. Saunders. (2006) The immune response, basic and clinical principles, pp. 484-486. Elsevier Academic Press, China. 162. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001 Jan 1;97(1):256-63. 163. Reikerås O, Helle A, Krohn CD, Brox JI. Systemic and local cytokine kinetics in musculoskeletal injury: a prospective study in patients with ankylosing spondylitis. Scand J Clin Lab Invest. 2009;69(2):198-203. 164. Neidhardt TR, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertrel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997;42:863-870. 165. Esmon CT. The interactions between inflammation and coagulation. HBr J Haematol.H 2005 Nov;131(4):417-430. 166. Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb).H 2012;22(1):49-62. 167. Edgcombe H, Carter K, Yarrow S. Anaesthesia in the prone position. Br J Anaesth. 2008 Feb;100(2):165-83. 168. Shukry M, D'Angelo JA, Joshi M, Cure JA, de Armendi AJ. Profound intraoperative metabolic acidosis and hypotension in a child undergoing multilevel spinal fusion. Case Rep Med. 2009;2009:190263. 169. Bain J Barbara, Bates Imelda, Laffan A Mike, Lewis S Mitchell. Dacie and Lewis Practical Haematology. Churchill Livingstone Elsevier, Health Sciences UK. 11th Ed. 2012. 225 170. Romih M, Delécrin J, Heymann D, Passuti N. The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow. Eur Spine J 2005 Sep;14(7):645-8. 171. Risbud MV, Shapiro IM, Guttapalli A, Di Martino A, Danielson KG, Beiner JM, Hillibrand A, Albert TJ, Anderson DG, Vaccaro AR. Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine (Phila Pa 1976) 2006 Jan 1;31(1):83-9. 172. Defino HL, da Silva Herrero CF, Crippa GE, Bellesini LS, Beloti MM, Rosa AL. In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest. Spine (Phila Pa 1976) 2009 Jul 1;34(15):1549-53. 173. Barbanti Brodano G, Terzi S, Trombi L, Griffoni C, Valtieri M, Boriani S, Magli MC. Mesenchymal stem cells derived from vertebrae (vMSCs) how best biological properties. Eur Spine J 2013 Nov;22 Suppl 6:S979-84. 174. Stem Cell Collection. Optimizing BM harvesting from normal adult donors. H Lannert, T Able, S Becker, M Sommer, M Braun, P Stadtherr, A D Ho. Bone Marrow Transplant. 2008; 42: 443–447. 175. Batinić D, Marusić M, Pavletić Z, Bogdanić V, Uzarević B, Nemet D, Labar B. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant. 1990 Aug;6(2):103-7. 176. Executive committee of the World Marrow Donor Association, Special report. Bone marrow transplants using volunteer donors - recommendations and requirements for a standardized practice throughout the world. Bone Marrow Transplant. 1992; 10: 287-291. 177. Muschler GF, Takigami H, Nakamoto C, Principles of bone fusion. The Spine, 5th edition, 1st volume; Rothman-Simeone, Saunders-Elsevier, Philadelphia. 2006, pp. 385-406. 178. J Davis, Basic Cell Culture: A Practical Approach. Oxford University Press, 2nd Ed., 2002. 179. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 180. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003 Jul 1;287(1):98-105. 181. Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, Kalbacher H, Bühring HJ. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev. 2013 Jul 1;22(13):1944-54. 182. Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L. Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue. Stem Cells Dev. 2015 Sep 15;24(18):2142-57. 226 183. Cuthbert RJ, Giannoudis PV, Wang XN, Nicholson L, Pawson D, Lubenko A, Tan HB, Dickinson A, McGonagle D, Jones E. Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration. PLoS One. 2015 Mar 11;10(3):e0117855. 184. Tomlinson MJ, Dennis C, Yang XB, Kirkham J. Tissue non-specific alkaline phosphatase production by human dental pulp stromal cells is enhanced by high density cell culture. Cell Tissue Res. 2015 Aug;361(2):529-40. 185. Kim YH, Yoon DS, Kim HO, Lee JW. Characterization of different subpopulations from bone marrow-derived mesenchymal stromal cells by alkaline phosphatase expression. Stem Cells Dev.2012 Nov 1;21(16):2958-68. 186. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012:975871. 187. Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A. 2014 Apr;20(7-8):1295-305. 188. Pippenger BE, Duhr R, Muraro MG, Pagenstert GI, Hügle T, Geurts J. Multicolour flow cytometry-based cellular phenotyping identifies osteoprogenitors and inflammatory cells in the osteoarthritic subchondral bone marrow compartment. Osteoarthritis Cartilage. 2015 Nov;23(11):1865-9. 189. Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y, Ohgushi H. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005 May-Jun;11(5-6):663-73. 190. Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods. 2012 Jun;18(6):453-63. 191. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012;2012:975871. 192. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999 Nov;265(1):134-9. 193. Boxall S, Jones E. The use of multiparameter flow cytometry and cell sorting to characterize native human bone marrow mesenchymal stem cells (MSC). Methods Mol Biol. 2015;1235:121-30. 194. Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun.2001 Nov 30;289(2):519-24. 195. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem. 2000 Mar 31;275(13):9645-52. 227 196. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004 Jun 1;329(1):77-84. 197. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol. 2011;698:253-78. 198. Temu TM, Wu KY, Gruppuso PA, Phornphutkul C. The mechanism of ascorbic acid-induced differentiation of ATDC5 chondrogenic cells. Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E325-34. 199. Tanaka H, Murphy CL, Murphy C, Kimura M, Kawai S, Polak JM. Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone. J Cell Biochem. 2004 Oct 15;93(3):454-62. 200. Cox G, Boxall SA, Giannoudis PV, Buckley CT, Roshdy T, Churchman SM, McGonagle D, Jones E. High abundance of CD271+ multipotential stromal cells (MSCs) in intramedullary cavities of long bones. Bone. 2012 Feb;50(2):510-7. 201. Baboolal TG, Boxall SA, Churchman SM, Buckley CT, Jones E, McGonagle D. Intrinsic multipotential mesenchymal stromal cell activity in gelatinous Heberden's nodes in osteoarthritis at clinical presentation. Arthritis Res Ther. 2014 Jun 3;16(3):R119. 202. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P, McGonagle D. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 2008 Jun;58(6):1731-40. 203. English A, Jones EA, Corscadden D, Henshaw K, Chapman T, Emery P, McGonagle D. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford). 2007 Nov;46(11):1676-83. 204. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 2004 Mar;50(3):817-27. 205. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol. 2011;698:253-78. 206. Keeney G, Leslie K. Preparing fresh tissues for the microscope. JAMA. 2008 Sep 3;300(9):1074-6. 207. Andrew H Fischer, Kenneth A Jacobson, Jack Rose, Rolf Zeller. Cryosectioning Tissues. This protocol was adapted from “Preparation of Cells and Tissues for Fluorescence Microscopy,” Chapter 4, Basic Methods in Microscopy (eds. Spector and Goldman). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2006. 208. Andrew H Fischer, Kenneth A Jacobson, Jack Rose, Rolf Zeller. Preparation of Slides and Coverslips for Microscopy. This protocol was adapted from “Preparation 228 of Cells and Tissues for Fluorescence Microscopy,” Chapter 4, Basic Methods in Microscopy (eds. Spector and Goldman). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2006. 209. Guo GH, Dong J, Yuan XH, Dong ZN, Tian YP. Clinical evaluation of the levels of 12 cytokines in serum/plasma under various storage conditions using evidence biochip arrays. Mol Med Rep. 2013 Mar;7(3):775-80. 210. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods. 1992 Aug 30;153(1-2):115-24. 211. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine. 2000 Nov;12(11):1712-6. 212. MRC Ethics Guide: Medical research involving children, Medical Research Council, 2004. 213. Catherine Shaw, Louca-Mai Brady and Ciara Davey. Guidelines for Research with Children and Young People. NCB Research Centre, 03/2011. 214. Kalton, G. Introduction to survey sampling. Newbury Park, CA: Sage, 1983. 215. Greene S, Hogan D. Researching children's experiences: methods and approaches. London: Sage, 1983. 216. Dal Pozzo S, Urbani S, Mazzanti B, Luciani P, Deledda C, Lombardini L, Benvenuti S, Peri A, Bosi A, Saccardi R. High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow. Cytotherapy 2010 Sep;12(5):579-86. 217. Bøyum, A. (1968) Separation of leucocytes from blood and bone marrow, Scand J Clin Lab Invest, 21, suppl.97. 218. Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology. 2015 Oct;71(2):181-97. 219. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289–301. 220. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003 Jul 1;287(1):98-105. 221. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy. 2001;3(5):393-6. 222. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-5. 229 223. Sarah Churchman and Elena Jones. The expression of novel mesenchymal/stromal lineage transcripts in uncultured CD271-positive MSCs: differences from culture-expanded MSCs. Excerpt from MACS & more Vol. 14 – 2/2012. 224. Wangen JR, Eidenschink Brodersen L, Stolk TT, Wells DA, Loken MR. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation. Int J Lab Hematol. 2014 Apr;36(2):184-96. 225. Jones E, Schäfer R. Biological differences between native and cultured mesenchymal stem cells: implications for therapies. Methods Mol Biol. 2015; 1235:105-20. 226. Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A. 2014 Apr;20(7-8):1295-305. 227. Aldridge A, Kouroupis D, Churchman S, English A, Ingham E, Jones E. Assay validation for the assessment of adipogenesis of multipotential stromal cells-a direct comparison of four different methods. Cytotherapy. 2013 Jan;15(1):89-101. 228. Naderi N, Wilde C, Haque T, Francis W, Seifalian AM, Thornton CA, Xia Z, Whitaker. Adipogenic differentiation of adipose-derived stem cells in 3-D spheroid cultures (microtissue): implications for the reconstructive surgeon. J Plast Reconstr Aesthet Surg. 2014 Dec;67(12):1726-34. 229. PA Fontes, C Ricordi, AS Rao, WB Rybka, SF Dodson, CG McAllister, B Broznick, FO Ukah, JJ Fung, TE Starzl. Human vertebral bodies as a source of bone marrow for cell augmentation in whole organ allografts Methods in Cell transplantation. ed: Camillo Ricordi. R.G. Landes Company 1994. Chapter H1:615-24. 230. Mansilla E, Mártire K, Roque G, Tau JM, Marín GH, Castuma MV, Orlandi G Tarditti A. Salvage of cadaver stem cells (CSCS) as a routine procedure: history or future for regenerative medicine. J. of Transplant Technol Res, 2013, 3:1. 231. Machalinski B, Kijowski J, Marlicz W, Gontarewicz A, Markiewski M, Paczkowski M, Kopkowski A, Majka M, Ostrowski M, Ratajczak MZ. Heparinized cadaveric organ donors (HCOD)-a potential source of hematopoietic cells for transplantation and gene therapy. Transplantation. 2001 Apr 15;71(7):1003-7. 232. Gambrall MA. Anaesthetic implications for surgical correction of scoliosis. AANA J. 2007 Aug;75(4):277-85. 233. Gessmann J, Köller M, Godry H, Schildhauer TA, Seybold D. Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia). 2012 Jan 2;4(1):e14. 234. Gigante A, Calcagno S, Cecconi S, Ramazzotti D, Manzotti S, Enea D. Use of collagen scaffold and autologous bone marrow concentrate as a one-step cartilage repair in the knee: histological results of second-look biopsies at 1 year follow-up. Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl 2):69-72. 230 235. Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA, Zimmermann G, Luginbühl R. Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur Cell Mater. 2008 Oct 23;16:47-55. 236. Kroschinsky F, Kittner T, Mauersberger S, Rautenberg U, Schuler U, Rutt C, Laniado M, Ehninger G. Pelvic magnetic resonance imaging after bone marrow harvest- retrospective study in 50 unrelated marrow donors. Bone Marrow Transplant. 2005 Apr;35(7):667-73. 237. Ortiz SS, Miller JH, Villablanca JG, Seeger RC. Bone abnormalities detected with skeletal scintigraphy after bone marrow harvest in patients with childhood neuroblastoma. Radiology. 1994 Sep;192(3):755-8. 238. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age related Osteogenic potential of Mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999 Jul;14(7):1115-22. 239. Friebert SE, Shepardson LB, Shurin SB, Rosenthal GE, Rosenthal NS. Pediatric bone marrow cellularity: are we expecting too much? J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):439-43. 240. Zhou Z, Jiang EL, Wang M, Liu QG, Zhai WJ, Huang Y, Wang HH, Han MZ Zhongguo. Comparative study on various subpopulations in mesenchymal stem cells of adult bone marrow. Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):54-8. 241. Kaltz N, Ringe J, Holzwarth C, Charbord P, Niemeyer M, Jacobs VR, Peschel C, Häupl T, Oostendorp RA. Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res. 2010 Oct 1;316(16):2609-17. 242. Elena Jones, Richard Schäfer. Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species? Stem Cell Res Ther. 2015; 6(1): 143. 243. Panepucci RA, Siufi JL, Silva WA Jr, Proto-Siquiera R, Neder L, Orellana M, Rocha V, Covas DT, Zago MA. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004;22(7):1263-78. 244. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006 Jun 1;119(Pt 11):2204-13. 245. Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J 2012 Oct 16;2(3):154-62. 246. Narbona-Carceles J, Vaquero J, Suárez-Sancho S, Forriol F, Fernández-Santos ME. Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest? Injury. 2014 Oct;45 Suppl 4:S42-7. 247. Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011 Feb;12(2):126-31. 248. Ackema KB, Charité J. Mesenchymal stem cells from different organs are characterized by distinct topographic Hox codes. Stem Cells Dev. 2008 Oct;17(5):979-91. 231 249. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec;46(12):3349-60. 250. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001 Jan;19(1):117-25. 251. Liu H, Toh WS, Lu K, MacAry PA, Kemeny DM, Cao T.A subpopulation of mesenchymal stromal cells with high osteogenic potential. J Cell Mol Med. 2009 Aug;13(8B):2436-47. 252. Ardeshirylajimi A, Soleimani M, Hosseinkhani S, Parivar K, Yaghmaei P.A comparative study of osteogenic differentiation human induced pluripotent stem cells and adipose tissue derived mesenchymal stem cells. Cell J. 2014 Fall;16(3):235-44. 253. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol. 2008;40(1):46-62. 254. A Rawls, RE Fisher. Development and Functional Anatomy of the Spine. The Genetics and Development of Scoliosis, Kusumi, S.L. Dunwoodie (eds.) C Springer Science Business Media 2010, Chapter 2: 21-46. 255. De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003 Mar 17;160(6):909-18. 256. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, Baggett LS, Mikos AG, Cao Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 2008 Oct 28;9:60. 257. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC.In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells.2010 Apr;28(4):788-98. 258. Gambrall MA. Anaesthetic implications for surgical correction of scoliosis. AANA J. 2007 Aug;75(4):277-85. 259. J. Matthew Kynes, Faye M. Evans. Surgical correction of scoliosis anaesthetic considerations. ATOTW 318, 10th July 2015. 260. Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty. 2016 Nov;31(11):2458-2464. 261. Takahashi J, Ebara S, Kamimura M, Kinoshita T, Misawa H, Shimogata M, Tozuka M, Takaoka K. Pro-inflammatory and anti-inflammatory cytokine increases after spinal instrumentation surgery. J Spinal Disord Tech. 2002 Aug;15(4):294-300. 262. Bosch P, Kenkre TS, Londino JA, Cassara A, Yang C, Waters JH. Coagulation Profile of Patients with Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion. J Bone Joint Surg Am. 2016 Oct 19;98(20):e88. 232 263. Ono S, Tsujimoto H, Hiraki S, Takahata R, Kinoshita M, Mochizuki H. Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery. Am J Surg 2005;190:439-444. 264. Sperry JL, Friese RS, Frankel HL, West MA, Cuschieri J, Moore EE, Harbrecht BG, Peitzman AB, Billiar TR, Maier RV, Remick DG, Minei JP; Inflammation and the Host Response to Injury Investigators. Male gender is associated with excessive IL-6 expression following severe injury. J Trauma. 2008 Mar;64(3):572-8. 265. Yeon Gu Chung, Yu Sam Won, Young Joon Kwon, Hyun Chul Shin, Chun Sik Choi, Joon-Sup Yeom. Comparison of Serum CRP and Procalcitonin in Patients after Spine Surgery. J Korean Neurosurg Soc. 2011 Jan; 49(1): 43–48. 266. Smith RM, Giannoudis PV, Bellamy MC, Perry SL, Dickson RA, Guillou PJ. Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing. Clin Orthop Relat Res. 2000 Apr;(373):233-40. 267. Peronnet E, Nguyen K, Cerrato E, Guhadasan R , Venet F, Textoris J, Pachot A, Monneret G, Carrol ED. Evaluation of mRNA Biomarkers to Identify Risk of Hospital Acquired Infections in Children Admitted to Paediatric Intensive Care Unit. PLoS One. 2016 Mar 25;11(3):e0152388. 268. de Almeida DC, Ferreira MR, Franzen J, Weidner CI, Frobel J, Zenke M, Costa IG, Wagner W. Epigenetic Classification of Human Mesenchymal Stromal Cells. Stem Cell Reports, 2016. 6(2): p. 168-75. 269. Brief report: Group 3 Innate Lymphoid Cells in Human Enthesis. Cuthbert RJ, Fragkakis EM, Dunsmuir R, Li Z, Coles M, Marzo-Ortega H, Giannoudis PV, Jones E, El-Sherbiny YM, McGonagle D. Arthritis Rheumatol. sep. 2017."],"dcterms:accessrights":["public"],"dc:title":["Characterisation of the immuno-inflammatory response following operative adolescent idiopathic scoliosis and biological properties of osteoprogenitor cells harvested from vertebral bodies compared to iliac crest."],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["M.D"]},"updated_at":"2026-11-18T22:24:19Z"}